Masakazu Kakuni
Director/Board Member at PHOENIXBIO CO., LTD.
Masakazu Kakuni active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PHOENIXBIO CO., LTD. | Director/Board Member | 31/05/2014 | - |
| Corporate Officer/Principal | 30/06/2009 | 30/11/2020 | |
KMT Hepatech, Inc.
 KMT Hepatech, Inc. Miscellaneous Commercial ServicesCommercial Services KMT Hepatech, Inc. provides vivo research services focusing on preclinical development of Hepatitis C, Hepatitis B, and Malaria therapeutics and vaccines. It offers scientific evaluation services for drug metabolism, lipoprotein metabolism, dose response, and drug treatment. The firm provides KMT Mouse, a transgenic mouse model for practical testing of HCV drug candidates. The company was founded by Norman Miles Kneteman, David F. Mercer and David Lorne John Tyrrell in 2001 and is headquartered in Edmonton, Canada. | President | 30/11/2020 | - |
Career history of Masakazu Kakuni
Statistics
International
| Japan | 2 |
| Canada | 2 |
Operational
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
| President | 1 |
Sectoral
| Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PHOENIXBIO CO., LTD. | Commercial Services |
| Private companies | 1 |
|---|---|
KMT Hepatech, Inc.
KMT Hepatech, Inc. Miscellaneous Commercial ServicesCommercial Services KMT Hepatech, Inc. provides vivo research services focusing on preclinical development of Hepatitis C, Hepatitis B, and Malaria therapeutics and vaccines. It offers scientific evaluation services for drug metabolism, lipoprotein metabolism, dose response, and drug treatment. The firm provides KMT Mouse, a transgenic mouse model for practical testing of HCV drug candidates. The company was founded by Norman Miles Kneteman, David F. Mercer and David Lorne John Tyrrell in 2001 and is headquartered in Edmonton, Canada. | Commercial Services |
- Stock Market
- Insiders
- Masakazu Kakuni
- Experience
